4.4 SNS Antagonists & False transmitters Flashcards
a1 receptors
- tissues
- functions
- Various (vascular, GI tract etc.)
- Vasoconstriction, relaxation of GI tract
α2 receptors
- tissues
- functions
- Presynaptic terminals, vascular smooth muscle, CNS
- Inhibition of transmitter release, vasoconstriction, CNS actions
β1 receptors
- tissues
- functions
- Heart, GI tract, kidneys
- Increased cardiac rate and force, relaxation of GI tract, renin release from kidneys
β2 receptors
- tissues
- functions
- Bronchi, smooth muscles, liver
- Bronchodilation, vasodilation, relaxation of visceral smooth muscle, hepatic glycogenolysis
β3 receptors
- tissues
- functions
- Adipose tissue
- Lipolysis
what is the selectivity for labetalol?
α1 + β1
what is the selectivity for phenotolamine?
α1 + α2
what is the selectivity for prazosin?
α1
what is the selectivity for propranolol?
β1 + β2
what is the selectivity for atenolol?
β1
Hypertension refers to an increase in blood pressure associated with increased risk of other diseases (sign rather than a disease itself):
• Underlying cause is rarely diagnosed (often primary hypertension)
• Defined by NICE guidelines as a blood pressure of__________________, or diagnosed with an ambulatory blood pressure monitoring (ABPM) daytime average or home blood pressure monitoring (HBPM) average of __________________
• Main contributing elements: blood volume, cardiac output, peripheral vascular tone
140/90 mmHg or higher;
135/85 mmHg or higher
The different β blockers (-olols) may be cardioselective (β1) or non-selective:
Competitive antagonism of the β1 adrenoceptors is responsible for most of the antihypertensive actions (unclear how effective β2 antagonism is):
• CNS effects: reduces sympathetic tone to various tissue targets
• Cardiac effects: reduces ____________ → not in chronic treatment
• Renal effects: reduces _____________ → chronic long-term benefit (due to blocking of the vasoconstrictor effects of angiotensin II)
The common long-term feature in the antihypertensive actions of these β adrenoceptor antagonists is the ____________________:
• Blockade of facilitatory effects of presynaptic β adrenoceptors on NA release may also contribute to the antihypertensive effect
heart rate and cardiac output;
renin production;
reduction in peripheral resistance (due to kidneys and angiotensin)
Why is β blockers dangerous in diabetics?
Use of β blockers masks the symptoms of hypoglycaemia (palpitations and tremors): • Non-selective antagonists are more dangerous in diabetics as they block β2-driven glycogenolysis
• β1-selective agents are advantageous as hepatic glucose release is controlled by β2 receptors
Why can’t β blockers be used in patients with acute/ unstable heart failure?
obstructive lung diseases (e.g. bronchitis) Cardiac failure
Treatment in chronic heart failure leads to reduced mortality:
• Cannot be used in acute/unstable heart failure due to acute negative inotropic effects
why is there bronchoconstriction due to β blockers?
Little importance in the absence of airway disease, but can be dramatic and life-threatening in asthmatic patients/other obstructive lung diseases (e.g. bronchitis)